Investing in China Cord Blood Corporation (CO)  ➔  Intrinsic value

Prev. close$4.86 
ModelValueUpside
Chepakovich$12.37+155%
Graham-Dodd$7.17+47%
Graham$19.49+301%
Previous Close$4.86  
Valuation MethodValuePotential 
Chepakovich Model$12.37+155%recalculate
Graham-Dodd$7.17+47%recalculate
Graham Formula$19.49+301%recalculate

Latest news

15 Mar

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal => PR Newswire 7:00AM

2 Mar

Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal => PR Newswire 7:00AM

25 Feb

Global Cord Blood Corp. to Host Earnings Call => ACCESSWIRE 6:15AM

24 Feb

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021 => PR Newswire 4:16PM

19 Feb

Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2021 Financial Results => PR Newswire 7:00AM

11 Feb

Global Cord Blood Corporation Announces Termination of Discussion Regarding Cordlife Merger Proposal => PR Newswire 7:00AM

5 Jan

Global Cord Blood Announces NHC Policy Update => PR Newswire 7:30AM

7 Dec

Is CO A Good Stock To Buy Now? => Insider Monkey 11:06PM

Global Cord Blood Corporation Announces Results of 2020 Annual General Meeting => PR Newswire 8:30AM

25 Nov

Global Cord Blood Corp. to Host Earnings Call => ACCESSWIRE 6:15AM

24 Nov

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021 => PR Newswire 4:16PM

18 Nov

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2021 Financial Results => PR Newswire 7:00AM

17 Sep

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2020 => PR Newswire 7:00AM

24 Aug

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021 => PR Newswire 4:16PM

18 Aug

Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results => PR Newswire 7:00AM

29 Jul

Global Cord Blood Corporation Files Its Annual Report on Form 20-F => PR Newswire 4:16PM

8 Jul

Edited Transcript of CO earnings conference call or presentation 30-Jun-20 12:00pm GMT => Thomson Reuters StreetEvents 12:17PM

30 Jun

Do Hedge Funds Like Global Cord Blood Corp (CO)? => Insider Monkey 11:32PM

29 Jun

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020 => PR Newswire 4:16PM

24 Jun

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2020 Financial Results => PR Newswire 7:30AM

29 May

10 Penny Stocks to Buy Under $5 That Might Be Worth the Risk => InvestorPlace 9:43AM

27 Apr

Global Cord Blood Corporation Provides Further Update on COVID-19 => PR Newswire 7:00AM

22 Apr

Those Who Purchased Herc Holdings (NYSE:HRI) Shares Three Years Ago Have A 56% Loss To Show For It => Simply Wall St. 8:20AM

8 Apr

Edited Transcript of CO earnings conference call or presentation 12-Mar-20 12:00pm GMT => Thomson Reuters StreetEvents 8:11AM

23 Mar

3 Medical Companies With the Strength to Weather Coronavirus Fears => GuruFocus.com 6:16PM

11 Mar

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020 => PR Newswire 4:16PM

9 Mar

Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2020 Financial Results => PR Newswire 7:00AM

Company description

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).